A Scots schoolboy has 'rang the bell' to celebrate beating cancer after his symptoms were originally mistaken for norovirus.

Nurix Therapeutics, Inc. stock slid 40% after promising NX-5948 results in CLL. NX-5948 shows efficacy in heavily pre-treated ...

China's National Medical Products Administration has approved a Phase III trial of InnoCare Pharma’s ICP-248 (Mesutoclax) ...

Discover how 18F-FDG PET and PET/CT provide critical diagnostic accuracy for detecting high-grade transformations in chronic ...

Recent studies show that HIV patients are 10 to 20 times more likely to develop lymphoma compared to individuals without HIV.

Although CAR T-cell therapies have been found effective against certain difficult-to-treat malignancies, they are not devoid of safety concerns.

This is the cold season, and many people are down with runny nose, fever, cough, and tiredness. However, according to experts ...

New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.

With positive mid-stage results in marginal zone lymphoma, Bristol Myers Squibb could soon add a new indication for the CAR T ...

With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in ...

Introduction: Donor lymphocyte infusion (DLI ... hematopoietic stem cell transplantation; LBL, lymphoblastic lymphoma; mcCR, molecular or cytogenetic complete remission; mcRL, molecular or cytogenetic ...